English (United Kingdom)Thai (ภาษาไทย)

Tentative result for EQAI 2014

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 

TRIAL 01-14-4

 
 

Control material NO.

01-14-4-1

01-14-4-2

01-14-4-3

01-14-4-4

Non treponemal test

Non Reactive

Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-14-4

 
 

Control material NO.

02-14-4-1

02-14-4-2

02-14-4-3

02-14-4-4

HBsAg (COI)

NEGATIVE
0.55± 0.15(ECLIA)

NEGATIVE
0.55± 0.16(ECLIA)

POSITIVE
387.28± 69.9(ECLIA)

POSITIVE
334.89± 61.17(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
336.10 ±92.70

POSITIVE
287.67 ± 64.10

NEGATIVE
1.20± 4.19

NEGATIVE
1.35±6.99

antiHBc

POSITIVE

NS

NS

NS

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

NS

NEGATIVE

NEGATIVE

 

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 

TRIAL 01-14-3

 
 

Control material NO.

01-14-3-1

01-14-3-2

01-14-3-3

01-14-3-4

Non treponemal test

Reactive

Non Reactive

Reactive

Non Reactive

Treponemal test

Reactive

Reactive

Reactive

Non Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-14-3

 
 

Control material NO.

02-14-3-1

02-14-3-2

02-14-3-3

02-14-3-4

HBsAg (COI)

NEGATIVE
0.57± 0.15(ECLIA)

POSITIVE
259.83± 35.10(ECLIA)

NEGATIVE
0.57± 0.14(ECLIA)

POSITIVE
276.76± 29.8(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
115.52 ±17.62

NEGATIVE
0.41 ± 0.60

POSITIVE
249.01± 34.56

NEGATIVE
0.50±0.68

antiHBc

NS

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

NEGATIVE

NS

NEGATIVE

 
 

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 

TRIAL 01-14-2

 
 

Control material NO.

01-14-2-1

01-14-2-2

01-14-2-3

01-14-2-4

Non treponemal test

Reactive

Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Reactive

Reactive

Non Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-14-2

 
 

Control material NO.

02-14-2-1

02-14-2-2

02-14-2-3

02-14-2-4

HBsAg

POSITIVE
5003.75± 343.71(CMIA)

POSITIVE
809.33± 64.16(CMIA)

NEGATIVE
0.41± 0.18(CMIA)

POSITIVE
1606.82± 94.56(CMIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
1.42 ±0.5

NEGATIVE
0.24 ± 0.55

POSITIVE
161.5± 66.7

NEGATIVE
0.43±0.55

antiHBc

POSITIVE

POSITIVE

NEGATIVE

POSITIVE

HBeAg

NEGATIVE

POSITIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

NEGATIVE

NEGATIVE

NEGATIVE

 

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 

TRIAL 01-14-1

 
 

Control material NO.

01-14-1-1

01-14-1-2

01-14-1-3

01-14-1-4

Non treponemal test

Reactive

Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Reactive

Reactive

Non Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-14-1

 
 

Control material NO.

02-14-1-1

02-14-1-2

02-14-1-3

02-14-1-4

HBsAg

NEGATIVE
0.27± 0.12
(CMIA)

NEGATIVE
0.26  ±  0.08
(CMIA)

NS

POSITIVE
699.21± 97.69
(CMIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
3.59 ± 5.80

NEGATIVE
2.37 ± 0.96

NEGATIVE
0.68± 0.82

NEGATIVE
0.83±1.68

antiHBc

NEGATIVE

NEGATIVE

NS

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

 

Search

Copyright © 2010 Faculty of Medical Technology, Mahidol University. All Rights Reserved. Download Internet Explorer 8 Top